PLX
Protalix BioTherapeutics, Inc. Common Stock
$2.33
-2.92%
-0.07
Notify me if price changes either direction
Buy PLX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
187.7M
Enterprise value
150.8M
Trailing PE
12.631579
Forward PE
3.8709679
PEG Ratio
-0.022556391071429
Enterprise to EBITDA
7.074
Enterprise to revenue
1.974
Price to book MRQ
2.877698
Price to sales TTM
2.5316758
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
76.4M
EBITDA
21.3M
Diluted EPS TTM
0.19
Total Cash (MRQ)
51.1M
Current ratio (MRQ)
3.153
Operating Cash Flow (TTM)
15.1M
PLX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
